(Total Views: 497)
Posted On: 05/11/2022 11:23:16 PM
Post# of 155739
Gotcha, but didn’t Kelly touch on this last CC or did he deflect ?
I thought he made it seem like they weren’t going to continue to look at the mTNBC data any further for BTD?
I also thought they stop giving Leronlimab to people once the trial was over.
Maybe the present the data show it’s better and then apply for BTD.
I thought he made it seem like they weren’t going to continue to look at the mTNBC data any further for BTD?
I also thought they stop giving Leronlimab to people once the trial was over.
Maybe the present the data show it’s better and then apply for BTD.
(1)
(0)
Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
